School of BioSciences, University of Melbourne, Parkville, Australia; Melbourne IVF, East Melbourne, Australia.
Kuramoto Women's Clinic, Reproductive Medicine, Fukuoka, Japan.
Reprod Biomed Online. 2020 May;40(5):637-644. doi: 10.1016/j.rbmo.2020.01.026. Epub 2020 Feb 5.
Does the inclusion of three antioxidants (A3), acetyl-l-carnitine (ALC), N-acetyl-l-cysteine (NAC) and alpha-lipoic acid (ALA) improve human embryo development and pregnancy potential?
Prospective randomized multicentre comparison of sibling oocytes. A total of 1563 metaphase II oocytes from 133 patients in two IVF centres. Day 3 embryo and day 5/6 blastocyst quality were assessed. Good embryo quality on day 3 was defined as 8 to 10 cells with even cells and low fragmentation; good quality blastocysts as 3BB or greater. Clinical outcome was assessed on transfers of fresh or vitrified-warmed blastocyst on day 5.
Of the two-pronuclei, 40.7% (G-Series) and 50.2% (G-Series with A3 group) resulted in good quality embryos on day 3 (P < 0.05). The implantation rate by fetal sac was 39.2% and 50.6%, and by fetal heartbeat was 37.8% and 47.1% for the G-Series and G-Series with A3 group, respectively. When stratified by female patient age, patients 35-40 years had an implantation rate by fetal sac and heart of 23.5% in the G-Series compared with 57.5% (P < 0.05) and 50.0% (P < 0.05) in the A3 group. The ongoing pregnancies in patients 35-40 years were significantly higher in the A3 group (50%) compared with the control (25.8%) (P < 0.05).
The presence of antioxidants during IVF and embryo culture for patients 35-40 years resulted in a significant increase in implantation and pregnancy rate. Supplementation of antioxidants to IVF and culture media may therefore improve the viability of human embryos in assisted reproductive technologies, plausibly through the reduction of oxidative stress.
三种抗氧化剂(A3)、乙酰左旋肉碱(ALC)、N-乙酰半胱氨酸(NAC)和α-硫辛酸(ALA)的添加是否能提高人类胚胎发育和妊娠潜能?
对来自两个 IVF 中心的 133 名患者的 1563 个中期 II 卵母细胞进行前瞻性随机多中心比较。评估第 3 天胚胎和第 5/6 天囊胚的质量。第 3 天胚胎质量良好定义为 8-10 个细胞,细胞均匀,碎片少;优质囊胚定义为 3BB 或更高。通过新鲜或玻璃化冷冻解冻囊胚在第 5 天的转移评估临床结局。
在原核期,40.7%(G 系列)和 50.2%(G 系列加 A3 组)的卵母细胞第 3 天形成良好的胚胎(P<0.05)。G 系列和 G 系列加 A3 组的妊娠囊种植率分别为 39.2%和 50.6%,胎心种植率分别为 37.8%和 47.1%。按女性患者年龄分层,35-40 岁患者 G 系列的妊娠囊和胎心种植率为 23.5%,而 A3 组分别为 57.5%(P<0.05)和 50.0%(P<0.05)。35-40 岁患者的持续妊娠率在 A3 组明显高于对照组(50%比 25.8%)(P<0.05)。
在 35-40 岁患者的 IVF 和胚胎培养过程中添加抗氧化剂可显著提高种植率和妊娠率。因此,在辅助生殖技术中向 IVF 和培养介质中添加抗氧化剂可能会提高人类胚胎的活力,这可能是通过减少氧化应激实现的。